Literature DB >> 26669476

Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.

Clifford A Courville1, S Vamsee Raju1, Bo Liu1, Frank J Accurso2, Mark T Dransfield1, Steven M Rowe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26669476      PMCID： PMC4731718          DOI： 10.1164/rccm.201502-0396LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees.

Authors:  N Kawakami; N Takatsuka; H Shimizu; H Ishibashi
Journal:  Am J Epidemiol       Date:  1997-01-15       Impact factor: 4.897

2.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Authors:  Bonnie W Ramsey; Jane Davies; N Gerard McElvaney; Elizabeth Tullis; Scott C Bell; Pavel Dřevínek; Matthias Griese; Edward F McKone; Claire E Wainwright; Michael W Konstan; Richard Moss; Felix Ratjen; Isabelle Sermet-Gaudelus; Steven M Rowe; Qunming Dong; Sally Rodriguez; Karl Yen; Claudia Ordoñez; J Stuart Elborn
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

3.  Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.

Authors:  Lucy A Clunes; Catrin M Davies; Raymond D Coakley; Andrei A Aleksandrov; Ashley G Henderson; Kirby L Zeman; Erin N Worthington; Martina Gentzsch; Silvia M Kreda; Deborah Cholon; William D Bennett; John R Riordan; Richard C Boucher; Robert Tarran
Journal:  FASEB J       Date:  2011-10-11       Impact factor: 5.191

4.  Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.

Authors:  S Vamsee Raju; Patricia L Jackson; Clifford A Courville; Carmel M McNicholas; Peter A Sloane; Gina Sabbatini; Sherry Tidwell; Li Ping Tang; Bo Liu; James A Fortenberry; Caleb W Jones; Jeremy A Boydston; J P Clancy; Larry E Bowen; Frank J Accurso; J Edwin Blalock; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

Review 5.  COPD-related morbidity and mortality after smoking cessation: status of the evidence.

Authors:  N S Godtfredsen; T H Lam; T T Hansel; M E Leon; N Gray; C Dresler; D M Burns; E Prescott; J Vestbo
Journal:  Eur Respir J       Date:  2008-10       Impact factor: 16.671

6.  Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.

Authors:  André M Cantin; John W Hanrahan; Ginette Bilodeau; Lynda Ellis; Annie Dupuis; Jie Liao; Julian Zielenski; Peter Durie
Journal:  Am J Respir Crit Care Med       Date:  2006-02-23       Impact factor: 21.405

7.  Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.

Authors:  James A Lambert; S Vamsee Raju; Li Ping Tang; Carmel M McNicholas; Yao Li; Clifford A Courville; Roopan F Farris; George E Coricor; Lisa H Smoot; Marina M Mazur; Mark T Dransfield; Graeme B Bolger; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

8.  β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.

Authors:  Paul Quinton; Laura Molyneux; Wan Ip; Annie Dupuis; Julie Avolio; Elizabeth Tullis; Douglas Conrad; A K Shamsuddin; Peter Durie; Tanja Gonska
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

9.  A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.

Authors:  Peter A Sloane; Suresh Shastry; Andrew Wilhelm; Clifford Courville; Li Ping Tang; Kyle Backer; Elina Levin; S Vamsee Raju; Yao Li; Marina Mazur; Suzanne Byan-Parker; William Grizzle; Eric J Sorscher; Mark T Dransfield; Steven M Rowe
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.

Authors:  Clifford A Courville; Sherry Tidwell; Bo Liu; Frank J Accurso; Mark T Dransfield; Steven M Rowe
Journal:  Respir Res       Date:  2014-02-25
View more
  10 in total

1.  Maternal Smoking Induces Acquired CFTR Dysfunction in Neonatal Rats.

Authors:  Lydia L McCormick; Scott E Phillips; Niroop Kaza; Li Ping Tang; Lawrence Rasmussen; Stephen A Byzek; S Vamsee Raju; Steven Mark Rowe
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

Review 2.  Seeing cilia: imaging modalities for ciliary motion and clinical connections.

Authors:  Jacelyn E Peabody; Ren-Jay Shei; Brent M Bermingham; Scott E Phillips; Brett Turner; Steven M Rowe; George M Solomon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-01       Impact factor: 5.464

Review 3.  The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Authors:  George M Solomon; Lianwu Fu; Steven M Rowe; James F Collawn
Journal:  Curr Opin Pharmacol       Date:  2017-11-10       Impact factor: 5.547

Review 4.  Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.

Authors:  S Vamsee Raju; George M Solomon; Mark T Dransfield; Steven M Rowe
Journal:  Clin Chest Med       Date:  2015-12-24       Impact factor: 2.878

5.  Pilot evaluation of ivacaftor for chronic bronchitis.

Authors:  George M Solomon; Heather Hathorne; Bo Liu; S Vamsee Raju; Ginger Reeves; Edward P Acosta; Mark T Dransfield; Steven M Rowe
Journal:  Lancet Respir Med       Date:  2016-05-16       Impact factor: 30.700

Review 6.  Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis.

Authors:  George M Solomon; S Vamsee Raju; Mark T Dransfield; Steven M Rowe
Journal:  Ann Am Thorac Soc       Date:  2016-04

Review 7.  Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Juan Shi; Hui Li; Chao Yuan; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Oxid Med Cell Longev       Date:  2018-04-23       Impact factor: 6.543

8.  Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.

Authors:  Gabriela R Oates; Elizabeth Baker; Joseph M Collaco; Steven M Rowe; Sarah B Rutland; Christopher M Fowler; William T Harris
Journal:  J Cyst Fibros       Date:  2021-07-17       Impact factor: 5.527

9.  Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults.

Authors:  Jeeyeon Kim; Miesha Farahmand; Colleen Dunn; Carlos E Milla; Rina I Horii; Ewart A C Thomas; Richard B Moss; Jeffrey J Wine
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

10.  Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis.

Authors:  Elizabeth Baker; William T Harris; Steven M Rowe; Sarah B Rutland; Gabriela R Oates
Journal:  J Cyst Fibros       Date:  2020-10-03       Impact factor: 5.527
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.